| Literature DB >> 28179897 |
Josephine C Moran1, Jamal A Alorabi1, Malcolm J Horsburgh1.
Abstract
Staphylococcal colonization of human skin is ubiquitous, with particular species more frequent at different body sites. Whereas Staphylococcus epidermidis can be isolated from the skin of every individual tested, Staphylococcus aureus is isolated from <5% of healthy individuals. The factors that drive staphylococcal speciation and niche selection on skin are incompletely defined. Here we show that S. aureus is inhibited to a greater extent than S. epidermidis by the sebaceous lipid sapienic acid, supporting a role for this skin antimicrobial in selection of skin staphylococci. We used RNA-Seq and comparative transcriptomics to identify the sapienic acid survival responses of S. aureus and S. epidermidis. Consistent with the membrane depolarization mode of action of sapienic acid, both species shared a common transcriptional response to counteract disruption of metabolism and transport. The species differed in their regulation of SaeRS and VraRS regulons. While S. aureus upregulated urease operon transcription, S. epidermidis upregulated arginine deiminase, the oxygen-responsive NreABC nitrogen regulation system and the nitrate and nitrite reduction pathways. The role of S. aureus ACME and chromosomal arginine deiminase pathways in sapienic acid resistance was determined through mutational studies. We speculate that ammonia production could contribute to sapienic acid resistance in staphylococci.Entities:
Keywords: RNA-Seq; Staphylococcus aureus; Staphylococcus epidermidis; colonization; fatty acid; sapienic acid; skin
Year: 2017 PMID: 28179897 PMCID: PMC5263133 DOI: 10.3389/fmicb.2017.00033
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains used in this study.
| Species | Strain | Description | Reference |
|---|---|---|---|
| Rp62a | Intravascular catheter isolate | ||
| Tü3298 | Epidermin producer | ||
| NCTC 1457 | PIA producer | ||
| A19 | Recent skin (forearm) isolate | ||
| B19 | Recent skin (forearm) isolate | ||
| O16 | Recent skin (forearm) isolate | ||
| BL115 | Recent nasal isolate | ||
| Newman | Osteomyelitis isolate | ||
| SH1000 | Lab strain (rsbU repaired 8325-4 derivative) | ||
| MSSA476 | Osteomyelitis isolate | ||
| MRSA252 | Fatal bacteraemia isolate, MRSA | ||
| BL014 | Recent nasal isolate | ||
| BL032 | Recent nasal isolate | ||
| SF8300 | CA-MRSA | ||
| SF8300ax | SF8300 with ACME deletion | ||
| Liv1245 | Newman arcA::tet from Liv692 | This study | |
| Liv1247 | SF8300 arcA::tet from Liv692 | This study | |
| Liv1249 | SF8300ax arcA::tet from Liv692 | This study | |
| Liv692 | S. aureus SH1000 arcA::tet | ||
| Newman tagO | tagO::ery from SA113 tagO | This study | |
| SA113 tagO | tagO::Ery | ||
| Newman | NWMN_0050:: Ery | This study | |
| Newman | Newman | This study | |
| Liv1023 | |||
| Liv1024 | |||
| RN4220 | Restriction deficient strain | ||
| SH1000 | |||
Primers used in this study.
| Gene name | Primer sequences | Efficiency (%) | Reference |
|---|---|---|---|
| F-GCGAACATGCAACGTCAAGR-GACCTCTGTGCTTAGCTGTAATAGC | 97.0 | This study | |
| F-TTTACGTGCAGCACGTTCACR-AAAAAGAAGCTGGTTCAGCAGTAG | 90.3 | ||
| F-AGAAAAGATGGGACGCCCTGR-CACCATGAAGACCGCCAGAT | 96.6 | This study | |
| F-ATCGACTTCAGAGAGAGGTTGR-CCGTTATCCGTTACTTTAATCCA | 92.9 | ||
| F-GCGATATGCGTAAGCCAACACR-GGTACAGGGCCAGCTGTTAG | 91.5 | This study | |
| F-CGATGTTTGGCGCAACAGTAR-GCTGGTATTTGCGCCTTCG | 92.5 | This study | |
| F-TGGTGCACCTCCAGGTTATGR-AGAATCCGTAAGACGACCTTCA | 99.0 | This study | |
| F-ACGCCAGCTGTGTGGATTATR-AACGACTGCGACCTTGATGT | 93.3 | This study | |
| F-TCACTCTGCGATTGAAGGCAR-TTTCCGGTGCCGAATGATCT | 95.0 | This study | |
| F-TGGCCTTTCCATTGCATCCTR-TTCAGTGTCGCCAGCAGTTA | 93.6 | This study | |
| F1-ACATGAATTCGGAATTGGTTAAGTTCACTCR1-CCGGTACCAGAACTCATCTAATA CAGACF2-ATAACTGCGGCCGCTGTATCACTTAGGTGTATCAR2-CGACGGATCCTCCAGCTGTTACCAGTCCGA | – | This study | |
| F-TTACGGATCCTTAAGTAACTTCTTTCAAR-TTATAAAGCTTACATCATTTCTGTCCCAG | – | This study | |